Clinical Medicine Research
Volume 5, Issue 3, May 2016, Pages: 24-27
Received: Mar. 24, 2016;
Accepted: Apr. 18, 2016;
Published: Apr. 28, 2016
Views 4738 Downloads 131
Albert Pesha, Service of Urology, Regional Hospital Fier, Fier, Albania
Benign prostatic hypertrophy can be treated by several therapeutic options including medical and surgical techniques. Among the surgical options, transurethral resection has a crucial role. Transurethral resection of the prostate (TURP) remains the standard surgical treatment for benign prostatic hypertrophy (BPH). This technique was the first minimally invasive procedure of the modern surgical practice remaining the most commonly procedure. During 2010-2015, 324 patients were enrolled in our study, recording all postoperative complications. Our paper emphasizes all the theoretical aspects of TURP’s complications comparing to our data.
Complications of Transurethral Resection of the Prostate, Clinical Medicine Research.
Vol. 5, No. 3,
2016, pp. 24-27.
Copyright © 2016 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/
) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Madersbacher S, Lackner J, Bro¨ ssner C, Ro¨ hlich M, Stancik I, Willinger M, Schatzl G. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol 2005; 47:499–504.
Westenberg A, Gilling P, Kennett K, Frampton C, Fraundorfer M. Homium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term followup. J Urol 2004; 172:616–9.
Keoghane SR, Sullivan ME, Doll HA, Kourambas J, Cranston DW. Five year data from the Oxford laser prostatectomy trial. BJU Int 2000; 86:227–8.
Bachmann A, Ruszat R, Wyler S, Reich O, Seifert HH, Mu¨ ller A, Susler T. Photoselective vaporization of the prostate: The Basel experience after 108 procedures. Eur Urol 2005; 47:798–804.
Zwergel U. Benignes Prostathyperplasie-(BPH)-Syndrom. Operative und interventionelle Therapieoptionen. Urologe A 2001; 40:319-29.
Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)-Incidence, management, and prevention. European Urology 2006; 50: 969-980.
Hoffmann R. Transurethrale rezection (TURP) und transurethrale incision der Prostat. In Hoffmann R, editor. Endoskopische Urologie. Heidelberg: Springer; 2005. P 50-84.
Heidler H. Frequency and causes of fluid absorption: a comparison of three techniques for resection of the prostate under continuous monitoring. BJU Int 1999; 83:619-22.
Colau A, Lucet J, Rufat P, Botto H, Benoit G, Jardin A. Incidence and risk factors of bacteria after transurethral resection of the prostate. Eur Urol 2001; 39:272-6.
Hubner W, Schlarp OM. Treatment of incontinence after prostatectomy using a new minimally invasive device: adjustable continence therapy. BJU Int 2005; 96:587-94.
Faul P Video-TUR:raising the gold standard. Eur Urol 1993; 24:256-61.
Horninger W, Unterlechner H, Strasser H, Bartsch G. Transurethral prostatectomy: mortality and morbidity. Prostate 1996; 28:195-8.
Mebust WK, Holtgreive HL, Cockett AT, Peters PC. Transurethral prostatectomy-immediate and postoperative complications: A comparative study of 13 participating institutions evaluating 3885 patients. J Urol 1989; 141:243-247.
Cullen DJ, Apolone G, Grenfield S, et al. ASA physical status and age predict morbidity after three surgical procedures. Ann Surg 1994; 220:3.
Malhotra V. Transurethral resection of the prostate. Anesthesiol Clin North Am 2000; 18: 883-897.